![Kristina Cutter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristina Cutter
Consigliere Generale presso ALECTOR, INC.
Profilo
Kristina Cutter currently works at Alector, Inc., as Chief Regulatory & Pharmacovigilance Officer.
Ms. Cutter also formerly worked at Genentech, Inc., as Head-Global Regulatory and Halozyme Therapeutics, Inc., as Vice President-Regulatory & Safety.
Ms. Cutter received her graduate degree from the University of Michigan School of Public Health.
Posizioni attive di Kristina Cutter
Società | Posizione | Inizio |
---|---|---|
ALECTOR, INC. | Consigliere Generale | 01/02/2019 |
Precedenti posizioni note di Kristina Cutter
Società | Posizione | Fine |
---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Kristina Cutter
University of Michigan School of Public Health | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
ALECTOR, INC. | Health Technology |
Aziende private | 1 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kristina Cutter